Literature DB >> 30323871

Differentially circulating exosomal microRNAs expression profiling in oral lichen planus.

Qiao Peng1, Jing Zhang1,2, Gang Zhou1,2.   

Abstract

Oral lichen planus (OLP) is a common chronic inflammatory autoimmune disease with unclear etiology. The aim of the present study was to identify the expression profiles of circulating exosomal miRNAs, which have been shown to be potent stimulators of inflammatory and immune responses, in OLP patients. Plasma exosomes were isolated from the patients and healthy individuals, and RAE scoring system was used to evaluate the severity of OLP. Differentially deregulated exosomal miRNAs associated with inflammatory response and autoimmunity in OLP were identified by miScript® miRNA PCR Array, and the results were confirmed by RT-PCR. The relationship between exosomal miRNAs and RAE scores was then analyzed, and bioinformatics analysis was used to predict the target genes and pathways of the differentially expressed exosomal miRNAs. Expression profiling showed that circulating exosomal miR-34a-5p and miR-130b-3p were upregulated, while miR-301b-3p was downregulated in OLP patients. Exosomal miR-34a-5p was positively correlated with the severity of OLP. Bioinformatics analysis revealed that the target genes of miR-34a-5p were mainly involved in regulation of gene expression, cell communication, signaling, and metabolic process, and modulated OLP progression through the PI3K/Akt signaling pathway. In conclusion, circulating exosomal miR-34a-5p could be a potential biomarker for evaluating the severity of OLP.

Entities:  

Keywords:  Oral lichen planus; exosomes; miRNAs; microarray; plasma

Year:  2018        PMID: 30323871      PMCID: PMC6176222     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  49 in total

Review 1.  Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.

Authors:  Fei Chen; Shen-Jiang Hu
Journal:  J Biochem Mol Toxicol       Date:  2011-12-12       Impact factor: 3.642

2.  Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus.

Authors:  W-Y Zhang; W Liu; Y-M Zhou; X-M Shen; Y-F Wang; G-Y Tang
Journal:  Oral Dis       Date:  2011-11-14       Impact factor: 3.511

Review 3.  Exosome-transported microRNAs of helminth origin: new tools for allergic and autoimmune diseases therapy?

Authors:  M Siles-Lucas; R Morchon; F Simon; R Manzano-Roman
Journal:  Parasite Immunol       Date:  2015-04       Impact factor: 2.280

Review 4.  Etiology and pathogenesis of oral lichen planus: an overview.

Authors:  Zoya B Kurago
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-03-19

5.  Different Expression of MicroRNA-146a in Peripheral Blood CD4(+) T Cells and Lesions of Oral Lichen Planus.

Authors:  Jian-Guang Yang; Ya-Ru Sun; Guan-Ying Chen; Xue-Yi Liang; Jing Zhang; Gang Zhou
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

6.  Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form.

Authors:  Gang Zhou; Kun Xia; Ge-fei Du; Xin-ming Chen; Xue-yi Xu; Rui Lu; Hong-mei Zhou
Journal:  J Oral Pathol Med       Date:  2009-08       Impact factor: 4.253

Review 7.  Recent advances of exosomes in immune modulation and autoimmune diseases.

Authors:  Lina Tan; Haijing Wu; Ying Liu; Ming Zhao; Duo Li; Qianjin Lu
Journal:  Autoimmunity       Date:  2016-06-03       Impact factor: 2.815

8.  Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.

Authors:  Manabu Akamatsu; Naohiko Makino; Yushi Ikeda; Akiko Matsuda; Miho Ito; Yasuharu Kakizaki; Yoshihiko Saito; Tetsuya Ishizawa; Toshikazu Kobayashi; Toru Furukawa; Yoshiyuki Ueno
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

9.  Expansion of the Gene Ontology knowledgebase and resources.

Authors: 
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

10.  MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.

Authors:  Jian-Jun Gu; Jian-He Zhang; Hong-Jie Chen; Shou-Sen Wang
Journal:  Int J Mol Med       Date:  2016-04-27       Impact factor: 4.101

View more
  7 in total

Review 1.  Possible roles of exosomal miRNAs in the pathogenesis of oral lichen planus.

Authors:  Congcong Li; Hong He; Jiaqin Wang; Xinyu Xia; Mengyun Zhang; Qingzhu Wu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases.

Authors:  Kaiyuan Xu; Qin Liu; Kaihui Wu; Liu Liu; Maomao Zhao; Hui Yang; Xiang Wang; Wenmei Wang
Journal:  J Transl Med       Date:  2020-11-12       Impact factor: 5.531

Review 3.  The Functional Mechanism of MicroRNA in Oral Lichen Planus.

Authors:  Yunshan Li; Yaodong He; Junwei Xiang; Linfei Feng; Yuanyin Wang; Ran Chen
Journal:  J Inflamm Res       Date:  2022-07-26

4.  Network Pharmacology and Molecular Docking Analysis Explores the Mechanisms of Cordyceps sinensis in the Treatment of Oral Lichen Planus.

Authors:  Hexin Ma; Guofang Wang; Xiaomeng Guo; Yao Yao; Chunshen Li; Xibo Li; Mingzhe Xin; Xiaohui Xu; Shilong Zhang; Zhi Sun; Hongyu Zhao
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

Review 5.  Emerging functions and clinical applications of exosomes in human oral diseases.

Authors:  Qiao Peng; Jing-Ya Yang; Gang Zhou
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

Review 6.  Emerging role of exosomes in craniofacial and dental applications.

Authors:  Xin Xing; Shuang Han; Zhi Li; Zubing Li
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 7.  Extracellular Vesicles in Head and Neck Cancer: A Potential New Trend in Diagnosis, Prognosis, and Treatment.

Authors:  Xinyu Qu; Jing-Woei Li; Jason Chan; Katie Meehan
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.